BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10554163)

  • 1. Detection of endometrial cancer by flow cytometry using two monoclonal antibodies.
    Kobiki K; Tsukasaki K; Kubushiro K; Kobayashi Y; Hasegawa K; Fukuchi T; Banno K; Nozawa S
    Cytometry; 1999 Jun; 36(2):150-6. PubMed ID: 10554163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric analysis of cell surface antigen recognized by monoclonal antibody (MSN-1) in normal, hyperplasia, and carcinoma of endometrial cells: its diagnostic value for endometrial carcinoma.
    Kobayashi Y; Tsukazaki K; Ohta K; Mikami M; Kubushiro K; Nozawa S
    Cytometry; 1997 Feb; 30(1):23-7. PubMed ID: 9056738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of a new supplementary diagnostic method for endometrial cancer by flow cytometry employing anti-endometrial cancer antibody, MSN-1 and MSN-3].
    Tsukazaki K; Kobiki K; Hasegawa K; Sakayori M; Nozawa S
    Nihon Rinsho; 1992 Oct; 50(10):2476-83. PubMed ID: 1280307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characterization of anti human uterine endometrial cancer antibody (MSN-1) and its usefulness in clinical application].
    Tsukazaki K; Sakuma Y; Kaneta Y; Sakayori M; Uchiyama M; Nozawa S
    Gan To Kagaku Ryoho; 1994 Feb; 21(2):141-9. PubMed ID: 8311483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A monoclonal antibody (MSN-1) against a newly established uterine endometrial cancer cell line (SNG-II) and its application to immunohistochemistry and flow cytometry.
    Nozawa S; Sakayori M; Ohta K; Iizuka R; Mochizuki H; Soma M; Fujimoto J; Hata J; Iwamori M; Nagai Y
    Am J Obstet Gynecol; 1989 Oct; 161(4):1079-86. PubMed ID: 2478021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of the monoclonal antibody to cultured uterine endometrial adenocarcinoma cells (EI)].
    Yudate T; Isaka K; Okabe K; Takayama M
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Jul; 47(7):635-42. PubMed ID: 7636334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of monoclonal antibodies MSN-1 and B72.3 in the prediction of the natural history of endometrial hyperplasia.
    Schwartz AM; Silverberg SG; Fu YS; Nozawa S; Huang S; Tsukasaki K; Williams KR
    Int J Gynecol Pathol; 1993 Jul; 12(3):253-8. PubMed ID: 8344762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth potential of endometrial cancers assessed by a Ki-67 Ag/DNA dual-color flow-cytometric assay.
    Yabushita H; Masuda T; Sawaguchi K; Noguchi M; Nakanishi M
    Gynecol Oncol; 1992 Mar; 44(3):263-7. PubMed ID: 1541439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of a quantitative assay of abnormal glycolipid expression in endometrial cells, and its diagnostic value for endometrial carcinoma.
    Kobayashi Y; Tsukazaki K; Kubushiro K; Sakayori M; Nozawa S
    Clin Cancer Res; 1996 Apr; 2(4):749-54. PubMed ID: 9816226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-CD9 monoclonal antibody-stimulated invasion of endometrial cancer cell lines in vitro: possible inhibitory effect of CD9 in endometrial cancer invasion.
    Park KR; Inoue T; Ueda M; Hirano T; Higuchi T; Konishi I; Fujiwara H; Fujii S
    Mol Hum Reprod; 2000 Aug; 6(8):719-25. PubMed ID: 10908282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biological effects of MSN-1 recognized antigen on tissue adhesion and metastasis in endometrial cancer].
    Kubushiro K; Tsukazaki K; Sakuma Y; Akiba Y; Sakayori M; Nozawa S
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Feb; 47(2):163-4. PubMed ID: 7706857
    [No Abstract]   [Full Text] [Related]  

  • 12. [Abnormal expression of glycoconjugate associated with the development of endometrial cancer: a basic study and its usefulness in clinical application].
    Tsukazaki K
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Aug; 45(8):789-801. PubMed ID: 8371008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
    McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
    Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential diagnosis between normal endometrium and endometrial hyperplasia with immunostaining cytology using anti-LeY monoclonal antibody.
    Arai Y; Nishida M
    Int J Gynecol Cancer; 2003; 13(1):42-6. PubMed ID: 12631219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Abnormal expression of carbohydrate chain and its mechanism in endometrial cancer].
    Kubushiro K; Tsukazaki K; Sakuma Y; Nozawa S
    Nihon Rinsho; 1995 Jul; 53(7):1753-9. PubMed ID: 7630016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CAR-3 and TAG-72 macromolecules in normal and transformed endometrium: potential diagnostic application in postmenopausal patients.
    Bartolazzi A; Mottolese M; Vocaturo A; Bigotti A; Vocaturo G; Atlante G; Prat M; Natali PG
    Cancer Res; 1991 Jun; 51(11):3001-5. PubMed ID: 2032237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and characterization of a monoclonal antibody (MSN-3) for uterine endometrial and endocervical adenocarcinoma.
    Hasegawa K; Tsukazaki K; Kubushiro K; Kobayashi Y; Kobiki K; Udagawa Y; Nozawa S
    Int J Oncol; 1997 Oct; 11(4):749-56. PubMed ID: 21528270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis, bcl-2 expression, and proliferation in benign and malignant endometrial epithelium: An approach using multiparameter flow cytometry.
    Morsi HM; Leers MP; Radespiel-Tröger M; Björklund V; Kabarity HE; Nap M; Jäger W
    Gynecol Oncol; 2000 Apr; 77(1):11-7. PubMed ID: 10739685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcellular localization of blood group Leb carbohydrate antigen (MSN-1-reactive antigen) in endometrial cancer cells.
    Susumu N; Kawakami H; Aoki D; Hirano H; Nozawa S
    Cancer Res; 1993 Aug; 53(15):3643-8. PubMed ID: 8339270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective cytotoxicity of adriamycin immunoconjugate of monoclonal antibody MSN-1 to endometrial adenocarcinoma in vitro and in vivo.
    Kaneta Y; Tsukazaki K; Kubushiro K; Sakayori M; Ueda M; Nozawa S
    Oncol Rep; 2000; 7(5):1099-106. PubMed ID: 10948346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.